182 related articles for article (PubMed ID: 35714907)
1. Higher Dose of CD34
Zhao F; Shi Y; Chen X; Zhang R; Pang A; Zhai W; Yang D; He Y; Feng S; Zhang P; Jiang E; Han M
Transplant Cell Ther; 2022 Sep; 28(9):589.e1-589.e10. PubMed ID: 35714907
[TBL] [Abstract][Full Text] [Related]
2. Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.
Zhou Z; Liu X; Zhang X; Wen S; Hua H; Wang Z; Xu Z; Lu Y; Wang F
J Inflamm Res; 2023; 16():2993-3008. PubMed ID: 37489148
[TBL] [Abstract][Full Text] [Related]
3. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
4. Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.
Minculescu L; Marquart HV; Friis LS; Petersen SL; Schiødt I; Ryder LP; Andersen NS; Sengeloev H
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2187-2193. PubMed ID: 27664326
[TBL] [Abstract][Full Text] [Related]
5. Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Glushkova S; Shelikhova L; Voronin K; Pershin D; Vedmedskaya V; Muzalevskii Y; Kazachenok A; Kurnikova E; Radygina S; Ilushina M; Khismatullina R; Maschan A; Maschan M
Transplant Cell Ther; 2024 Apr; 30(4):435.e1-435.e12. PubMed ID: 38278183
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
7. Impact of Cytomegalovirus Reactivation and Natural Killer Reconstitution on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Analysis.
Ando T; Suzuki T; Ishiyama Y; Koyama S; Tachibana T; Tanaka M; Kanamori H; Nakajima H
Biol Blood Marrow Transplant; 2020 Jan; 26(1):171-177. PubMed ID: 31563574
[TBL] [Abstract][Full Text] [Related]
8. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
9. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
10. Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation.
Park KH; Ryu JH; Bae H; Yun S; Jang JH; Han K; Cho BS; Kim HJ; Lee H; Oh EJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455959
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ
Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M
Front Immunol; 2019; 10():2504. PubMed ID: 31736949
[TBL] [Abstract][Full Text] [Related]
12. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia.
Savani BN; Mielke S; Adams S; Uribe M; Rezvani K; Yong AS; Zeilah J; Kurlander R; Srinivasan R; Childs R; Hensel N; Barrett AJ
Leukemia; 2007 Oct; 21(10):2145-52. PubMed ID: 17673900
[TBL] [Abstract][Full Text] [Related]
13. Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
Minculescu L; Fischer-Nielsen A; Haastrup E; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Sengelov H; Marquart HV
Front Immunol; 2020; 11():1068. PubMed ID: 32547559
[TBL] [Abstract][Full Text] [Related]
14. Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
Kheav VD; Busson M; Scieux C; Peffault de Latour R; Maki G; Haas P; Mazeron MC; Carmagnat M; Masson E; Xhaard A; Robin M; Ribaud P; Dulphy N; Loiseau P; Charron D; Socié G; Toubert A; Moins-Teisserenc H
Haematologica; 2014 Dec; 99(12):1860-7. PubMed ID: 25085354
[TBL] [Abstract][Full Text] [Related]
15. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse.
Luo XH; Poiret T; Liu Z; Meng Q; Nagchowdhury A; Ljungman P
Front Immunol; 2022; 13():1027593. PubMed ID: 36824620
[TBL] [Abstract][Full Text] [Related]
16. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
17. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
[TBL] [Abstract][Full Text] [Related]
18. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J
Front Immunol; 2018; 9():389. PubMed ID: 29545802
[TBL] [Abstract][Full Text] [Related]
19. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation.
Ureshino H; Shindo T; Sano H; Kubota Y; Ando T; Kidoguchi K; Kusaba K; Itamura H; Kojima H; Kusunoki Y; Miyazaki Y; Kojima K; Tanaka H; Saji H; Oshima K; Kimura S
Int J Hematol; 2020 May; 111(5):733-738. PubMed ID: 31873846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
